The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.
Frank, Guido K W
The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. [electronic resource] - The International journal of eating disorders Apr 2017 - 447-450 p. digital
Publication Type: Journal Article
1098-108X
10.1002/eat.22704 doi
Adolescent
Anorexia Nervosa--drug therapy
Aripiprazole--pharmacology
Body Mass Index
Dopamine Agonists--pharmacology
Female
Humans
Receptors, Dopamine D2--agonists
Retrospective Studies
Reward
Treatment Outcome
Weight Gain--drug effects
The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. [electronic resource] - The International journal of eating disorders Apr 2017 - 447-450 p. digital
Publication Type: Journal Article
1098-108X
10.1002/eat.22704 doi
Adolescent
Anorexia Nervosa--drug therapy
Aripiprazole--pharmacology
Body Mass Index
Dopamine Agonists--pharmacology
Female
Humans
Receptors, Dopamine D2--agonists
Retrospective Studies
Reward
Treatment Outcome
Weight Gain--drug effects